Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026

About this update from Evolus, Inc. Common Stock

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/045cc190ccd0ae0036fa8da4085bad24"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dENgIJa7gPtJ5VPYH17.QQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/045cc190ccd0ae0036fa8da4085bad24","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/uTioAusHraPox8JtaYIT9g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/045cc190ccd0ae0036fa8da4085bad24","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Total Net Revenue of $90.3 Million for the Fourth Quarter and $297.2 Million for the Full-Year 2025, Representing Growth of 14% and 12% Over the Prior Year","length":155,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Delivered GAAP Operating Income of $4.2 Million for the Fourth Quarter; Non-GAAP Operating Income of $7.1 Million for Q4 2025, Above Prior Guidance Range","length":153,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Full-Year GAAP Operating Expenses of $229.8 Million in 2025; Non-GAAP Operating Expense of $209.7 Million, Within the Company’s Guidance Range of $208 Million to $213 Million, with Second Half 2025 Expenses Declining 4% Compared to the First Half, Driving Meaningful Year-Over-Year Operating Leverage in the Second Half","length":319,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"2026 Net Revenue Guidance of $327 Million to $337 Million, Which Represents 10% to 13% Growth from 2025 Results","length":111,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"2026 Non-GAAP Operating Expense Guidance Reflects Meaningful Operating Leverage, With Only 0% to 3% Year-Over-Year Growth Resulting in a Range of $210 Million to $216 Million; Company Expects to Achieve a Low- to Mid-Single Digit Adjusted EBITDA Margin in 2026","length":260,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":998,"olType":false},{"type":"text","content":"NEWPORT BEACH, Calif., March 03, 2026--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on buildin...

More updates from Evolus, Inc. Common Stock